VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Tackling the unmet needs in GvHD from prophylaxis to treatment

Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, briefly discusses the challenge of preventing graft-versus-host disease (GvHD) in patients undergoing stem cell transplantation, and how the approval of agents including belumosudil and ruxolitinib have greatly improved outcomes for patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter